These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 26201060)
1. The role of mTOR during cisplatin treatment in an in vitro and ex vivo model of cervical cancer. Leisching GR; Loos B; Botha MH; Engelbrecht AM Toxicology; 2015 Sep; 335():72-8. PubMed ID: 26201060 [TBL] [Abstract][Full Text] [Related]
2. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737 [TBL] [Abstract][Full Text] [Related]
3. A nontoxic concentration of cisplatin induces autophagy in cervical cancer: selective cancer cell death with autophagy inhibition as an adjuvant treatment. Leisching G; Loos B; Botha M; Engelbrecht AM Int J Gynecol Cancer; 2015 Mar; 25(3):380-8. PubMed ID: 25695544 [TBL] [Abstract][Full Text] [Related]
4. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway. Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel. Faried LS; Faried A; Kanuma T; Nakazato T; Tamura T; Kuwano H; Minegishi T Eur J Cancer; 2006 May; 42(7):934-47. PubMed ID: 16540312 [TBL] [Abstract][Full Text] [Related]
6. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy. Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563 [TBL] [Abstract][Full Text] [Related]
7. Activation of mTOR signaling pathway contributes to survival of cervical cancer cells. Ji J; Zheng PS Gynecol Oncol; 2010 Apr; 117(1):103-8. PubMed ID: 20102778 [TBL] [Abstract][Full Text] [Related]
8. Rapamycin enhanced the antitumor efficacy of oxaliplatin in cisplatin-resistant ovarian cancer cells A2780cis both in vitro and in vivo. Liu J; Zhang L; Zhang X; Xing X J Chemother; 2015; 27(6):358-64. PubMed ID: 25976336 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance. Leisching G; Loos B; Botha M; Engelbrecht AM J Transl Med; 2015 Oct; 13():328. PubMed ID: 26474854 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer. Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554 [TBL] [Abstract][Full Text] [Related]
11. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. Li B; Yang J; Lu Z; Liu B; Liu F J BUON; 2019; 24(2):739-745. PubMed ID: 31128031 [TBL] [Abstract][Full Text] [Related]
12. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells. Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350 [TBL] [Abstract][Full Text] [Related]
13. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin]. Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689 [TBL] [Abstract][Full Text] [Related]
14. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes. Saber MM; Al-Mahallawi AM; Nassar NN; Stork B; Shouman SA BMC Cancer; 2018 Aug; 18(1):822. PubMed ID: 30111296 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Zhang L; Wang H; Xu J; Zhu J; Ding K Toxicol Lett; 2014 Aug; 228(3):248-59. PubMed ID: 24875536 [TBL] [Abstract][Full Text] [Related]
16. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer. Zhu H; Wu J; Zhang W; Luo H; Shen Z; Cheng H; Zhu X Sci Rep; 2016 Aug; 6():30788. PubMed ID: 27492148 [TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells. Kim HJ; Lee SY; Kim CY; Kim YH; Ju W; Kim SC Oncotarget; 2017 Jan; 8(4):6608-6622. PubMed ID: 28036259 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity. deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641 [TBL] [Abstract][Full Text] [Related]
19. Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Kim SH; Park EJ; Lee CR; Chun JN; Cho NH; Kim IG; Lee S; Kim TW; Park HH; So I; Jeon JH Int J Oncol; 2012 May; 40(5):1683-90. PubMed ID: 22200837 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of induced autophagy increases apoptosis of Nara-H cells. Nakamura O; Hitora T; Akisue T; Kawamoto T; Yamagami Y; Yamamoto T Int J Oncol; 2011 Dec; 39(6):1545-52. PubMed ID: 21805033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]